Medical devices, business development / C-level executive, MBA

RICHARD S. MINK

**** *. ******* ****, *******, PA 19067

609-***-**** ************@*******.***

SUMMARY

C-level commercialization expert, MBA, focused on value creation via business development, business analytics and marketing

/ sales management within the healthcare industry. Entrepreneurial, with in depth experience in start-ups, mergers, turnarounds,

product / technology alliance negotiations, and new product identification / development. Influential leader, customer-focused,

P&L-driven with a vision for creating market opportunities with innovative medical technologies.

PROFESSIONAL EXPERIENCE

June 2014 – March 2015

LIFE SCIENCE PLUS, INC, Mountain View, CA

(Commercial stage medical device company@ $1.2MM revenue in topical and surgical hemostasis products)

Chief Operating Officer

Directed all commercial / value creation activities, worldwide

Expanded the U.S. sales organization (added 47 reps plus manager) and distributor network in international markets (added 11 distributors representing new registrations in 52 countries).

Created marketing package of clinical, technical and other support materials to enable domestic and international sales teams to more effectively detail the company’s products

2012 – 2014

AESTHETIC FACTORS, LLC, Wayne, NJ

(Commercial stage medical device company@ $2.0MM revenue engaged in the collection, processing and re-injection of autologous tissues (blood and fat) for aesthetic applications in plastic, dermatologic and cosmetic surgery markets)

Chief Executive Officer

Transitional CEO brought in to reverse a declining trend in revenue and earnings and establish a sound strategic foundation for future growth.

Restructured and expanded the U.S. sales organization and distribution in international markets; halted negative sales trend.

Established an international support package to enable aligned distributors to expand mar keting efforts with minimal cost.

Resolved issues of continuous backorders and lack of forecasting / coordination with manufacturing requirements.

Developed strategies for revenue growth, expansion of product claims in the U.S. and ultimate viable exit opportunities

XYLOS CORPORATION, Langhorne, PA 2001 - 2012

(Development stage biomaterials-technology company focused in biocellulose products for topical and implantable medical devices)

Vice President, Business Development

Directed all business development and marketing activities of the Company.

Completed 2 M&A transactions in discrete applications of the company’s biocellulose technology.

Successfully launched the XCell wound care line through a distribution partner and transitioned the business to a larger, more effective player. Led the business development process in achieving the sales of the wound care business unit.

DERMA SCIENCES, INC., Princeton, NJ 1997 - 2000

(Turn-around situation in a NASDAQ small cap wound & skin care produ cts company @ $11MM revenue. Requested to join Derma Sciences by the same CEO as Life Medical / MedChem.)

Chief Operating Officer / Executive V.P.

Directed the day-to-day-operations of the company with functional responsibility for marketing, regulatory, technical & clinical development, product sourcing, and distribution.

Key member of due diligence team that completed two acquisitions expanding base revenue from $4MM to $11MM and market capitalization (at time of closing) from $6MM to $13MM.

Developed the strategic vision and plan for the merged companies, integrated functions & created new, cooperative culture.

Developed and launched initiatives for e-commerce and retail market expansion achieving $250k in incremental revenue @ 78% gross margin in first three months, with a first year projection of $2M - $3M. .

1995 – 1997

MEDICAL TECHNOLOGY BUSINESS CONSULTANTS, INC.

(Established a sole-proprietorship consulting practice in medical devices and biotech ;

Led early stage medical technology companies in formulating overall business strategies and commercialization programs. Key engagements included:

Biopharmaceuticals - Developed a business plan for a biotech firm with a novel platform technology in metallo -peptide drug development. Prepared the Company's initial investor package and collateral materials. Served as head of business

development, initiating collaborations with pharmaceutical firms in Europe, Japan and the U.S.

Hematology Lab Capital Equipment - Negotiated the terms of a multi-year alliance between an early stage company and a worldwide market leader.

Hypodermic Needle Safety Systems - Assessed U.S. market potential and strategy for a U.K.-based company with a unique technology. Participated in venture capital fund-raising efforts.

MEDCHEM, INC. / LIFE MEDICAL SCIENCES, INC. 1993 - 1995

(Joined Life Medical Sciences, Inc., a start-up company, that merged with MedChem Products, Inc., a $30MM specialty medical device company, in August, 1994. MedChem, Inc. was purchased by C.R. Bard in May, 1995.)

1994 – 1995

Executive Vice President, Surgical Specialties Div. (MedChem - Woburn, MA)

Led the Surgical Specialties Division with full P&L responsibility. Directed all activities for a $16MM business in the areas of plastic, general, orthopedic, cardiovascular, dermatologic and neurologic surgery. Managed a 30 person sales organization, 2 product managers, financial analyst and a customer service function.

Transitioned the sales, marketing and customer service functions following the company merger.

Developed the strategic, operational and financial plan with a projected growth of 24%.

Led the successful negotiations of a licensing and distribution agreement with a European firm.

1993 – 1994

Vice President, Worldwide Marketing & Sales (Life Medical Sciences - Princeton, NJ)

Initiated the marketing/sales function and developed strategies for launching a new technology addressing wound management in multiple surgical specialties. Led a 25 person sales and marketing organization.

Achieved $2.7MM in first year revenue in a new technology product launch within a newly formed company.

Established and trained distributors throughout Europe and the Far East, facilitating initial sales in those markets.

Developed the company's investor’s program and co-presented. Achieved a $12MM commitment in venture funding.

BECTON DICKINSON COMPANY, Franklin Lakes, NJ 1977 - 1993

(A $3.8B global healthcare corporation)

Director of Marketing (B-D Division) 1988 - 1993

Directed all strategic planning and marketing/sales implementation activities for a $75MM segment in anesthesia, radiology and broad usage hospital disposables.

Manager, Business Planning and Development (Corporate) 1986 - 1988

Assessed and coordinated participation in new technology opportunities outside the company's core business. Negotiated joint technology development agreements with companies and universities.

Product Manager (Vacutainer Systems Division) 1983 - 1986

Responsible for a $45MM line of products in laboratory diagnostics, including planning, forecasting and all marketing activities.

Marketing Research Positions (Mgr – Sr. Analyst (BD and Vacutainer Systems Division) 1977 - 1983

Conducted primary and secondary research for a $250MM division including hospital and laboratory disposables.

EDUCATION

MBA Marketing/Finance -- Rutgers University Graduate School of Management

BS Biology/Chemistry -- Rutgers University College of Arts and Sciences

Contact this candidate